Showing results (11-20 of 85) with videos related to
Sort By:
Pageof 9
Gastroenterology|October 18, 2019
Therapeutic Targeting of the Colorectal Tumor StromaWolf H Fridman, Ian Miller, Catherine Sautès-Fridman, et al.Immunology Letters|January 13, 2006
The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activationIsabelle Isnardi, Pierre Bruhns, Georges Bismuth, et al.Virchows Archiv : an International Journal of Pathology|January 12, 2019
Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncologyNicolas A Giraldo, J David Peske, Catherine Sautès-Fridman, et al.Seminars in Immunology|December 8, 2022
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?Wolf H Fridman, Sophie Sibéril, Guilhem Pupier, et al.Virchows Archiv : an International Journal of Pathology|June 17, 2015
The immune response in cancer: from immunology to pathology to immunotherapyNicolas A Giraldo, Etienne Becht, Yann Vano, et al.Frontiers in Immunology|May 28, 2020
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade TherapiesFlorent Petitprez, Maxime Meylan, Aurélien de Reyniès, et al.Journal of Leukocyte Biology|May 2, 2007
LPS induces rapid IL-10 release by M-CSF-conditioned tolerogenic dendritic cell precursorsWing-Hong Kwan, Charlotte Boix, Nicolas Gougelet, et al.Current Opinion in Immunology|March 20, 2018
Immune-based identification of cancer patients at high risk of progressionYann-Alexandre Vano, Florent Petitprez, Nicolas A Giraldo, et al.The Journal of Biological Chemistry|October 1, 2004
Two distinct tyrosine-based motifs enable the inhibitory receptor FcgammaRIIB to cooperatively recruit the inositol phosphatases SHIP1/2 and the adapters Grb2/GrapIsabelle Isnardi, Renaud Lesourne, Pierre Bruhns, et al.Antibodies (Basel, Switzerland)|October 29, 2020
Complement System: Promoter or Suppressor of Cancer Progression?Margot Revel, Marie V Daugan, Catherine Sautés-Fridman, et al.Pageof 9